Spiro Kevin Sakiris
Known title: ChiefFinancial OfficerCIK: 0001830957
Spiro Kevin Sakiris's purchase track record
Spiro Kevin Sakiris has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/17/2022 | INBS | $13K | -29.6% | -49.6% | +4.8% |
| 12/6/2021 | INBS | $17K | -46.8% | -63.5% | -10.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| INBS | ▲ Buy | Grant | 21,350 | $0 | 3/18/2026 | View on chart |
| INBS | ▲ Buy | Grant | 9,150 | $0 | 3/18/2026 | View on chart |
| INBS | ▲ Buy | Grant | 34,500 | $0 | 9/25/2024 | View on chart |
| INBS | ▼ Sell | Other | 9,394 | — | 3/20/2024 | View on chart |
| INBS | ▲ Buy | Open Market | 112,727 | — | 10/4/2023 | View on chart |
| INBS | ▼ Sell | Other | 2,399 | $14K | 5/10/2023 | View on chart |
| INBS | ▲ Buy | Grant | 75,000 | $0 | 10/10/2022 | View on chart |
| INBS | ▲ Buy | Open Market | 5,000 | $3K | 6/22/2022 | View on chart |
| INBS | ▲ Buy | Open Market | 15,970 | $10K | 6/17/2022 | View on chart |
| INBS | ▲ Buy | Open Market | 10,000 | $17K | 12/6/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
INBS Included in List of 12 Health Care Stocks Moving After-Market
Intelligent Bio Solutions was highlighted in a Benzinga report listing 12 health care stocks that saw movement during Thursday's after-market session. The stock currently trades near its 52-week low, with an RSI of 31.9 indicating oversold conditions. This inclusion suggests heightened short-term trading activity, though the company remains a high-beta name with significant volatility.
INBS Included in List of 12 Health Care Stocks Moving After-Market. Intelligent Bio Solutions was highlighted in a Benzinga report listing 12 health care stocks that saw movement during Thursday's after-market session. The stock currently trades near its 52-week low, with an RSI of 31.9 indicating oversold conditions. This inclusion suggests heightened short-term trading activity, though the company remains a high-beta name with significant volatility.